Small-molecule peptides inhibit Z α1-antitrypsin polymerization

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2304-2316

  Chang, Yi Pin ^a   Mahadeva, Ravi ^b   Chang, Wun Shaing W ^c   Lin, Sheng Chieh ^c   Chu, Yen Ho ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antitrypsin; Cirrhosis; Combinatorial chemistry; Emphysema; Peptide; Polymerization; Surface plasmon resonance; Urea gel

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOPOLYMER; PEPTIDE;

ARTICLE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; SURFACE PLASMON RESONANCE;

ALPHA 1-ANTITRYPSIN; BIOPOLYMERS; CELL LINE; HUMANS; PEPTIDES; SURFACE PLASMON RESONANCE;

EID: 72949086203     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00608.x     Document Type: Article

References (48)

1. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988 84 : 13 31.
2. Mahadeva R, Lomas DA. Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 1998 53 : 501 505.
3. 1-antitrypsin. Nat Struct Biol. 1996 3 : 676 681.
4. 1- proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model, and preliminary analysis of the implications for function. J Mol Biol. 1984 177 : 531 557.
5. Stratikos E, Gettins PWG. Major proteinase movement upon stable serpin-pro teinase complex formation. Proc Natl Acad Sci USA. 1997 94 : 453 458.
6. Stratikos E, Gettins PWG. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into β-Sheet A. Proc Natl Acad Sci USA. 1999 96 : 4808 4813.
7. Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 2000 407 : 923 926.
8. 1-Antitrypsin deficiency - A model for conformational diseases. N Eng J Med. 2002 346 : 45 53.
9. 1-antitrypsin-related emphysema. Am J Respir Cell Mol Biol. 2004 31 : 133 139.
10. Lomas DA, Evans DL, Finch JT, et al. The mechanism of Z alpha1-antitrypsin accumulation in the liver. Nature. 1992 357 : 605 607.
11. 1-antitrypsin deficiency. Am J Physiol. 2004 286 : G851 62.
12. 1-antitrypsin. Biochemistry. 1993 32 : 500 508.
13. Lieberman J, Mittman C, Gordon HW. Alpha1 antitrypsin in the livers of patients with emphysema. Science. 1972 175 : 63 5.
14. 1-antitrypsin by a monoclonal antibody. J Biol Chem. 2002 277 : 26540 26546.
15. 1- Antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest. 2004 125 : 1952 1957.
16. 1- antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol. 2005 166 : 377 386.
17. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005 365 : 2225 2236.
18. Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nat Rev Genet. 2002 3 : 759 768.
19. 1-antitrypsin polymers are formed by reactive loop beta-sheet A linkage. J Biol Chem. 2000 275 : 33663 33668.
20. Schulze AJ, Baumann U, Knof S, et al. Structural transition of alpha1-antitrypsin by a peptide sequentially similar to beta-strand s4A. Eur J Biochem. 1990 194 : 51 6.
21. Björk I, Nordling K, Larsson I, et al. Kinetic characterization of the substrate reaction between a complex of antithrombin with a synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor. J Biol Chem. 1992 267 : 19047 19050.
22. Chang WSW, Wardell MR, Lomas DA, et al. Probing serpin reactive loop conformations by proteolytic cleavage. Biochem J. 1996 314 : 647 653.
23. Fitton HL, Pike RN, Carrell RW, et al. Mechanisms of antithrombin polymerisation and heparin activation probed by insertion of synthetic reactive loop peptides. Biol Chem. 1997 378 : 1059 1063.
24. Skinner R, Chang WSW, Jin L, et al. Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin. J Mol Biol. 1998 283 : 9 14.
25. 1-antitrypsin related cirrhosis. J Biol Chem. 2002 277 : 6771 6774.
26. Zhou A, Stein PE, Huntington JA, et al. How small peptides block and reverse serpin polymerization. J Mol Biol. 2004 342 : 931 941.
27. Chowdhury P, Wang W, Lavender S, et al. Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides. J Mol Biol. 2007 369 : 462 473.
28. Horton DA, Bourne GT, Smythe ML. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev. 2003 103 : 893 930.
29. McFarland EW, Weinberg WH. Combinatorial approaches to materials design. TIBTECH. 1999 17 : 107 115.
30. Kim W, Kim Y, Min J, et al. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem Biol. 2006 1 : 461 469.
31. 1-antitrypsin. Am J Respir Cell Mol Biol. 2006 35 : 540 548.
32. Furka Á. Combinatorial chemistry: 20 years on. Drug Discov Today. 2002 7 : 1 7.
33. 1-proteinase inhibitor in β-Sheet A. Biochemistry. 1992 31 : 7560 7565.
34. 1-proteinase inhibitor probed by limited proteolysis. Biochemistry. 1992 31 : 2720 2728.
35. Chou PY, Fasman GD. Empirical predictions of protein conformation. Annu Rev Biochem. 1978 47 : 251 276.
36. Dooley CT, Chung NN, Wilkes BC, et al. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science. 1994 266 : 2019 2022.
37. Yu Z, Tu J, Chu YH. Tight-binding streptavidin ligands from a cyclic peptide library. Anal Chem. 1997 69 : 4515 4518.
38. Chenna R, Sugawara H, Koike T, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003 31 : 3497 3500.
39. Rich RL, Myszka DG. Survey of the year 2005 commercial optical biosensor literature. J Mol Recognit. 2006 19 : 478 534.
40. Chang YP, Chu YH. Using surface plasmon resonance to directly determine binding affinities of combinatorially selected cyclopeptides and their linear analogs to a streptavidin chip. Anal Biochem. 2005 340 : 74 9.
41. Chang YP, Tseng MJ, Chu YH. Using surface plasmon resonance to directly measure slow binding of low-molecular mass inhibitors to a VanX chip. Anal Biochem. 2006 359 : 63 71.
42. 1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem. 2007 50 : 5357 5363.
43. Taylor WR. The classification of amino acid conservation. J Theor Biol. 1986 119 : 205 218.
44. Cabrita LD, Dai W, Bottomley SP. Different conformational changes within the F-Helix occur during serpin folding, polymerization, and proteinase inhibition. Biochemistry. 2004 43 : 9834 9839.
45. 1- antitrypsin that play structural and functional roles. Protein Sci. 2001 10 : 1446 1453.
46. 1-antitrypsin deficiency. Chest. 2002 122 : 1818 1829.
47. Stoller JK, Fallat R, Schluchter MD, et al. Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. Chest. 2003 123 : 1425 1434.
48. Gildea TR, Shermock KM, Singer ME, et al. Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2003 167 : 1387 1392.